Abstract
Platelets contribute to primary hemostasis and their function is affected by their number and condition. Platelets arise from the fragmentation of megakaryocytes in the bone marrow, and circulate in the blood as disk-shaped non-nucleated particles, with a lifespan of 7–10 days. Their average diameter is about 1.5 µm, 20% of the diameter of erythrocytes. Once released from the bone marrow, young platelets enter the circulation, where a large proportion pool in the spleen. It has been suggested that this splenic sequestration of young platelets is the result of a longer transit time of large platelets through the splenic cords. The spleen serves as a reservoir for platelets, containing about one-third, which are then able to enter the circulation after exercise or epinephrine administration. In addition to the spleen, the lungs also contain a small pool of platelets, perhaps 10–15% of the total number, and these are also able to enter the circulation after exercise or epinephrine administration [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sola MC, Christensen RD (2000) Developmental aspects of platelets and disorders of platelets in the neonatal period. In: Christensen RD (ed) Hematologic problems of the neonate. Saunders, Philadelphia, pp 273–309
Handin RI (2003) Blood platelets and the vessel wall. In: Nathan DG (ed) Hematology of infancy and childhood. Saunders, Philadelphia, pp 1457–1474
Kühne T, Imbach P (1998) Neonatal platelet physiology and pathophysiology. Eur J Pediatr 157: 87–94
Blanchette VS, Rand ML (1997) Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol 21: 53–62
Sutor AH (1995) Thrombocytosis in childhood. Semin Thromb Hemostasis 21: 330–339
Dame C, Sutor AH (2005) Primary and secondary thrombocytosis in childhood. Br J Haematol 29: 165–177
Halperin DS, Washer P, Lacourt G (1990) Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study. J Pediatr 116: 779–786
Matsubara K, Baba K, Nigami H (2001) Early elevation of serum thrombopoietin levels and subsequent thrombocytosis in healthy preterm infants. Br J Haematol 115: 963–968
Kivivouri SM, Rajantie J, Siimes MA (1996) Peripheral blood cell counts in infants with Down’s syndrome. Clin Genet 49: 15–19
Gasparini N, Franzese A, Argenziano A (1996) Thrombocytosis in congenital adrenal hyperplasia at diagnosis. Clin Pediatr 35: 267–269
Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD (2009) Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol 29: 130–136
Sola-Visner M, Sallmon H, Brown R (2009) New insights into the mechanisms of nonimmune thrombocytopenia in neonates. Semin Perinatol 33: 43–51
Murray NA (2002) Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Acta Paediatr Suppl 438: 74–81
Bussel JB, Corrigan JJ (1995) Platelet and vascular disorders. In: Miller DR, Baehner RL (eds) Blood Diseases of Infancy and Childhood. Mosby, St. Louis, pp 866–923
Sola MC, Rimsza LM (2002) Mechanisms underlying thrombocytopenia in the neonatal intensive care unit. Acta Paediatr Suppl 438: 66–73
Watts TL, Murray NA, Roberts IAG (1999) Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. Pediatr Res 46: 28–32
Geddis AE (2009) Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Hematol Oncol Clin North Am 23: 321–331
MacMillan ML, Davies SM, Wagner JE (1998) Engraftment of unrelated donor stem cells in children with familial amegakaryocytic thrombocytopenia. Bone Marrow Transplant 21: 735–737
Bader-Meunier B, Tchernia G, Mielot F (1997) Occurrence of myeloproliferative disorders with Noon syndrome. J Pediatr 130: 885–889
Bussel JB, Sola-Visner M (2009) Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 33: 35–42
Williamson L, Hackett G, Rennie J (1998) The natural history of fetomaternal alloimmunization to the platelet specific antigen HPA- 1A as determined by antenatal screening. Blood 92: 2280–2287
Roberts I, Stanworth S, Murray NA (2008) Thrombocytopenia in the neonate. Blood Rev 22: 173–86
Velat AS, Caulier MT, Devos P (1998) Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia. Br J Haematol 103: 397–401
Bussel JB (1997) Immune thrombocytopenia in pregnancy: Autoimmune and alloimmune. J Reprod Immunol 37: 35–61
Sola-Visner M, Saxonhouse MA, Brown RE (2008) Neonatal thrombocytopenia: what we do and don’t know. Early Hum Dev 84: 499–506
Zipursky A, Jaber HM (1978) The haematology of bacterial infection in newborn infants. Clin Haematol 7: 175–193
Manzoni P, Arisio R, Mostert M et al (2006) Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 117: 22–32
Sola MC, Del Vecchio A, Rimsza LM (2000) Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Clin Perinatol 27: 655–679
Edstrom CS, Christensen RD, Andrew M (2000) Developmental aspects of blood hemostasis and disorders of coagulation and fibrinolysis in the neonatal period. In: Christensen RD (ed) Hematologic problems of the neonate. Saunders, Philadelphia, pp 239–271
Saxonhouse MA, Rimsza LM, Stevens G et al (2006) Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonates. Biol Neonate 89: 104–108
Clapp DW, Shannon KM, Phibbs RH (2001) Hematologic problems. In: Klaus MH, Fanaroff AA (eds) Care of the High Risk Neonate. Saunders, Philadelphia, pp 447–479
Nair S, Ghosh K, Kulkarni B et al (2002) Glanzmann’s thrombasthenia: updated. Platelets 13: 387–393
Poon MC (2007) The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders. Transfus Med Rev 21: 223–236
Sheffield MJ, Schmutz N, Lambert DK et al (2009) Ibuprofen lysine administration to neonates with a patent ductus arteriosus: effect on platelet plug formation assessed by in vivo and in vitro measurements. J Perinatol 29:39–43
Del Vecchio A, Sullivan SE, Christensen RD et al (2002) Indomethacin prolongs the bleeding time in neonates significantly more than ibuprofen. Pediatr Res 51:466A
Cheung PY, Salas E, Schulz R (1997) Nitric oxide and platelet function: Implications for neonatology. Semin Perinatol 21:409–417
Sola MC, Del Vecchio A, Edwards TJ et al (2001) The relationship between hematocrit and bleeding time in very low birth weight infants during the first week of life. J Perinatol 21: 368–371
Del Vecchio A, Sola MC (2000) Performing and interpreting the bleeding time in the neonatal intensive care unit. Clin Perinatol 27: 643–654
Del Vecchio A (2002) Use of the bleeding time in the neonatal intensive care unit. Acta Paediatr Suppl 91: 82–86
Saxonhouse MA, Sola MC (2004) Platelet function in term and preterm neonates. Clin Perinatol 31: 15–28
Saxonhouse MA, Sola MC, Pastos KM et al (2004) Reticulated platelet percentages in term and preterm neonates. J Pediatr Hematol Oncol 26: 797–802
Sola MC, Rimsza LM, Christensen RD (1999) A bone marrow biopsy technique suitable for use in neonates. Br J Haematol 107: 458–460
Christensen RD (2002) Advances and controversies in neonatal ICU platelet transfusion practice. Adv Pediatr 55: 255–269
Murray NA, Howarth LJ, McCloy MP et al (2002) Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 12: 35–41
Josephson CD, Su LL, Christensen RD et al (2009) Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 123: 278–285
Del Vecchio A, Sola MC, Theriaque DW et al (2001) Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions. Transfusion 41: 803–808
Del Vecchio A, Latini G, Henry E, Christensen RD (2008) Template bleeding times of 240 neonates born at 24 to 41 weeks gestation. J Perinatol 28: 427–431
Baer VL, Lambert DK, Henry E et al (2007) Do platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system. J Perinatol 27: 790–796
Gerday E, Baer VL, Lambert DK et al (2009) Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Transfusion 49: 2034–2039
Christensen RD, Paul DA, Sola-Visner MC, Baer VL (2008) Improving platelet transfusion practices in the neonatal intensive care unit. Transfusion 48: 2281–2284
Strauss RG (2008) How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity. Transfusion 48: 209–217
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Del Vecchio, A. (2012). Coagulation Disorders: Clinical Aspects of Platelet Disorders. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Milano. https://doi.org/10.1007/978-88-470-1405-3_102
Download citation
DOI: https://doi.org/10.1007/978-88-470-1405-3_102
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1404-6
Online ISBN: 978-88-470-1405-3
eBook Packages: MedicineMedicine (R0)